)
Nektar Therapeutics (NKTR) investor relations material
Nektar Therapeutics TD Cowen 46th Annual Health Care Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic focus and pipeline developments
Refocused R&D efforts on immunology, particularly regulatory T cells, driving a transformation in pipeline strategy.
Lead molecule REZPEG targets Treg cells, with clinical success in large indications such as atopic dermatitis.
Recent collaboration with UCSF to advance TNFR2 program in multiple sclerosis studies.
Strong financial position following a significant equity raise.
Clinical trial results and efficacy insights
Phase II-B trial of REZPEG in atopic dermatitis showed dose-dependent efficacy, with 24 mcg/kg twice monthly achieving statistical significance across endpoints.
Maintenance data at 52 weeks demonstrated high durability, with up to 85% maintaining IGA response and one in three patients achieving complete skin clearance (EASI-100).
REZPEG outperformed standard of care DUPIXENT in maintaining efficacy with less frequent dosing.
Rapid onset of itch relief and efficacy in comorbid asthma observed.
Safety and tolerability profile
Over 1,000 patients treated with REZPEG; safety profile consistent across studies with low discontinuation rates.
No increased risk of infection or immunosuppression; most common adverse event was injection site reactions (ISRs), which decreased with lower dosing frequency.
ISRs generally mild and self-resolving, with ongoing efforts to further mitigate them through formulation and delivery improvements.
Next Nektar Therapeutics earnings date
Next Nektar Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)